'Truly remarkable' drug helps motor neurone disease

United Kingdom News News

'Truly remarkable' drug helps motor neurone disease
United Kingdom Latest News,United Kingdom Headlines
  • 📰 BBCScienceNews
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 53%

Scientists say they have slowed and partially reversed damage, marking a 'new era' in the disease.

Les Wood, 68, from South Yorkshire, was the first British patient in the international trial,MND had forced him, an electrician, and his wife, Val, a nurse, to give up their careers, as walking and using his hands became more difficult.

After six months of therapy, those getting the drug had lower levels of SOD1 but were physically no better. She told me: "This is the first where patients participating have reported improvement in their motor function - 'I can walk without my sticks. I can go up my garden steps, which I haven't been able to do for two years. I can write my Christmas cards this year, which I couldn't do last year.'"

"It may take time for people to heal from the damage that has already been caused," said Dr Timothy Miller, the principal investigator, at Washington University.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BBCScienceNews /  🏆 87. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Motor neurone disease: 'Milestone' treatment slows or even reverses progressive muscle weakness, study findsMotor neurone disease: 'Milestone' treatment slows or even reverses progressive muscle weakness, study findsPatients having monthly injections of the drug tofersen reported better mobility and lung function after a year of treatment - with one who was in a wheelchair at the start of the trial now able to walk without sticks.
Read more »

Glucocorticoid-glucocorticoid receptor-HCN1 channels reduce neuronal excitability in dorsal hippocampal CA1 neurons - Molecular PsychiatryGlucocorticoid-glucocorticoid receptor-HCN1 channels reduce neuronal excitability in dorsal hippocampal CA1 neurons - Molecular PsychiatryMolecular changes in the brain in aftermath of traumatic event may help explain long-term susceptibility or resilience MCG_AUG MolPsychiatry
Read more »

Detroit is once again betting on the car industry to rescue itDetroit is once again betting on the car industry to rescue itBut the Motor City’s health will depend on more than motor cars
Read more »



Render Time: 2025-02-21 13:33:06